MBBS , MD – Internal Medicine, FNB – Infectious Disease, CIC
Dr. Divya Joshi is a qualified internist with specialist training in infectious diseases. She has 3 years of training experience in general medicine and 2 years of exclusive experience in infectious diseases as a part of my superspecialist training. In these years, she observed and independently managed a wide array of cases in the outpatient setting as well as the inpatient department, including the intensive care unit. She chose this field because it ties her love for applied physiology to providing quality care for patients. She has a passion for acute medicine and is adept at handling diagnostic challenges while making swift and appropriate decisions. She finds it especially fulfilling to solve clinical problems by working as part of a multidisciplinary team. She has developed a particular interest in infections in extracorporeal life support therapies and transplant and cancer-related infections.
Principal investigator: “Epidemiology and Outcomes of infections during Extracorporeal Membrane Oxygenation in adult patients with COVID-19 ARDS- A single center study” (As part of FNB Infectious Disease, research project.) 2021-23
Principal investigator: “Pregnancy associated with Systemic Lupus Erythematosus, Clinical Profile and Outcome; A study based in tertiary care centre.” (As part of MD Internal Medicine dissertation.) 2017-19
Coauthored a multicentric genomic study titled “Emergence of carbapenem-resistant Salmonella typhi harboring blaNDM-5 in India: genomic evidence from a multicenter study” published in Frontiers in Microbiology.
Coauthored chapter titled ‘Treatment of Non-Fermenting Gram Negative Bacteria’ in CIDS Update book. 2025
First author in study titled “Epidemiology and outcome of infections during extracorporeal membrane oxygenation in adult patients with COVID-19 ARDS- A single center study” published in Indian Journal of Medical Microbiology. Feb 2024,
First author in case report titled “Infective Endocarditis caused by Aspergillus fumigatus following CAPA (Covid Associated Pulmonary Aspergillosis)”, published in Fungal Infection Study Forum (FISF).
Second author in study titled “Pulmonary Mucormycosis in the Pre-Covid era: A Retrospective Study from South India”, published in Journal of Clinical Infectious Disease Society .
Second author in study titled “post-COVID multisystem inflammatory syndrome in adults: a study from a tertiary care hospital in south India” published in Indian Journal of Medical Research.
First author in case report titled “Pulmonary Blastomycosis Masquerading as Malignancy in India; Case from a Tertiary Hospital in South India.” published in International Journal of Travel Medicine and Global Health.
Authored a chapter titled “Anticoagulation in COVID-19” in COVID-19 SECOND WAVE IN INDIA HOW DIFFERENT FROM FIRST by Dr Kamlesh Tewary, Evangel. Author(s)-Dr Kamlesh Tewary, Publisher-Evangel 2021
First author in case report titled “A case of Pulmonary Alveolar Proteinosis in a middle-aged female.” Published in International Journal of Scientific Research.
We are a healthcare group founded by endocrinologists. Our vision is to provide personalized and evidence based health care for patients with Endocrine Disorders?.
Common disorders include Diabetes, Obesity, Thyroid dysfunction and PCOS. All these disorders require repeated examination by the doctor, quality laboratory evidence based prescribing, nurse /dietitian educators, podiatrist, preventive cardiologist, urologist and many more professionals. We endeavor to bring this integrated healthcare team under one roof at an affordable cost to our patients with endocrine problems.
All the information of the website is published in good faith and for general information purpose only. Any action you take upon the information you find on the website is strictly at your own risk. We will not be liable for any losses/ or damages in connection with the use of our website. By using our website, you hereby consent to our disclaimer and agree to its terms.
